There are 6 papers on visceral-to-subcutaneous fat ratio in aging research: 6 observational studies in people.
6 papers study it3 more mention it5 findings
“higher VSR (HR 1.17, 95% CI 1.01-1.37, P = .04) were independently associated with higher all-cause mortality”
- Humans6
Associations
3Mortality
upin humans3HR 1.17–6.6
3 studies
Mortality
upin humans3HR 1.17–6.6
Visceral-to-subcutaneous fat ratio is linked with a higher risk of mortality in humans (patients admitted with sepsis) (HR 6.6 (95% CI: 1.4-30.6; p = 0.016)).
“The adjusted HR for mortality was 6.6 (95% CI: 1.4-30.6; p = 0.016).”
Humanspatients admitted with sepsisn = 62
Revista clinica espanola
Visceral-to-subcutaneous fat ratio predicts mortality in humans (hemodialysis patients) (HR 1.17, 95% CI 1.01-1.37, P = .04).
“higher VSR (HR 1.17, 95% CI 1.01-1.37, P = .04) were independently associated with higher all-cause mortality”
Humanshemodialysis patientsmedian follow-up of 4.9 yearsn = 344
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Visceral-to-subcutaneous fat ratio predicts mortality in humans (liver transplant recipients) (P = .046).
“The deceased patient group had a statistically higher pretransplant visceral-to-subcutaneous fat ratio than the survival group (P = .046).”
Humansliver transplant recipientsn = 65
Effect of Pretransplant Sarcopenia on Mortality in Liver Transplant Recipients
Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation
Readmission
upin humans1HR 3.1
1 study
Readmission
upin humans1HR 3.1
Visceral-to-subcutaneous fat ratio is linked with a higher risk of readmission in humans (patients admitted with sepsis) (HR 3.1 (95% CI: 1.1-8.5; p = 0.026)).
“The HR for readmission was 3.1 (95% CI: 1.1-8.5; p = 0.026).”
Humanspatients admitted with sepsisn = 62
Revista clinica espanola
Non-cardiovascular mortality
upin humans1HR 1.29
1 study
Non-cardiovascular mortality
upin humans1HR 1.29
Visceral-to-subcutaneous fat ratio predicts non-cardiovascular mortality in humans (hemodialysis patients) (HR 1.29, 95% CI 1.09-1.54, P = .003).
“higher VSR (HR 1.29, 95% CI 1.09-1.54, P = .003) were also associated with cardiovascular and non-cardiovascular mortality, respectively.”
Humanshemodialysis patientsmedian follow-up of 4.9 yearsn = 344
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association